Detalhe da pesquisa
1.
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
N Engl J Med
; 376(7): 652-662, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199814
2.
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis.
Ann Rheum Dis
; 79(10): 1290-1297, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32788396
3.
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
Clin Exp Rheumatol
; 38(4): 732-741, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452344
4.
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.
Mod Rheumatol
; 30(1): 36-43, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784354
5.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
N Engl J Med
; 374(13): 1243-52, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028914
6.
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
Ann Rheum Dis
; 78(7): 890-898, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31040122
7.
Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
Ann Rheum Dis
; 78(2): 171-178, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194275
8.
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.
Ann Rheum Dis
; 77(7): 988-995, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463520
9.
Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.
Rheumatology (Oxford)
; 57(5): 900-908, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415145
10.
Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study.
Mod Rheumatol
; 28(1): 20-29, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440680
11.
Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.
Mod Rheumatol
; 28(4): 583-591, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29134891
12.
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
Ann Rheum Dis
; 76(11): 1853-1861, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28798049
13.
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
Ann Rheum Dis
; 76(1): 88-95, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27689735
14.
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).
Ann Rheum Dis
; 76(4): 694-700, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799159
15.
Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis.
Health Qual Life Outcomes
; 15(1): 239, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212515
16.
Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis.
Health Qual Life Outcomes
; 15(1): 237, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208004
17.
Safety and efficacy of baricitinib at 24â weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.
Ann Rheum Dis
; 74(2): 333-40, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431052
18.
Hurdles in new drug development in rheumatic diseases.
Joint Bone Spine
; 91(4): 105672, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042361
19.
Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis.
Rheumatology (Oxford)
; 50(8): 1458-65, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21441551
20.
Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade.
Ann Rheum Dis
; 69(4): 706-14, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19460761